Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.
News|Articles|February 3, 2026
Contemporary OB/GYN's top video interviews from January 2026
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor
Take a look back at any of our expert video interviews you may have missed from January 2026.
Advertisement
Advertisement
With each headline, clinical guideline update, FDA pipeline action item, and so many more topics that impact women’s health, we feel it is crucial to get leading expert reaction and commentary to assist in our coverage. Our expert interviews are key to providing insight into new clinical trial data, the latest news, and opinions or reminders for delivering the best care for your patients.
Related to this article
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
Jessica Shepherd, MD, MBA, FACOG, joins Missed & Dismissed to discuss why perimenopause is overlooked and how disparities shape who gets care.
Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Advertisement
Advertisement